ENOV|Enovis Corp|Price:22.590|Chg%:0.80

More Details of Enovis Corp Company

Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).

Enovis Corp Info



Ticker SymbolENOV

Company nameEnovis Corp

IPO dateMay 08, 2008

CEOMcdonald (Damien)

Number of employees7367

Security typeOrdinary Share

Fiscal year-endMay 08

Address2711 Centerville Road

CityWILMINGTON

Stock exchangeNASDAQ OMX NASDAQ Basic NYSE

CountryUnited States of America

Postal code19808

Phone13022529160

Websitehttps://www.enovis.com/

Ticker SymbolENOV

IPO dateMay 08, 2008

CEOMcdonald (Damien)

Company Executives of Enovis Corp



Name

Name/Position

Position

Shareholding

Change

Mr. Daniel Alexis Pryor

Executive Vice President - Strategy and Business Development

113.85K

-666.00%

Mr. Terry D. Ross

Group President - Prevention and Recovery

35.79K

-325.00%

Ms. Sharon L. Wienbar

Independent Chairman of the Board

28.26K

+6598.00%

Mr. Rajiv Vinnakota

Independent Director

20.37K

+6598.00%

Mr. Liam J. Kelly

Independent Director

15.27K

+6598.00%

Ms. Barbara W. Bodem

Independent Director

10.52K

+6598.00%

Dr. Christine Ortiz, Ph.D.

Independent Director

10.52K

+6598.00%

Mr. A. Clayton Perfall

Independent Director

--

Mr. Brady R. Shirley

Director

--

Mr. Bradley J. (Brad) Tandy, J.D.

Senior Vice President, Chief Legal Officer

--

Name

Name/Position

Position

Shareholding

Change

Mr. Daniel Alexis Pryor

Executive Vice President - Strategy and Business Development

113.85K

-666.00%

Mr. Terry D. Ross

Group President - Prevention and Recovery

35.79K

-325.00%

Ms. Sharon L. Wienbar

Independent Chairman of the Board

28.26K

+6598.00%

Mr. Rajiv Vinnakota

Independent Director

20.37K

+6598.00%

Mr. Liam J. Kelly

Independent Director

15.27K

+6598.00%

Ms. Barbara W. Bodem

Independent Director

10.52K

+6598.00%

Revenue Breakdown

Currency: USDUpdated: Tue, Jan 6

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

By BusinessUSD

Name

Revenue

Proportion

International Reconstructive

128.99M

23.50%

U.S. Reconstructive

128.98M

23.50%

U.S. Bracing & Support

126.98M

23.13%

International P&R

92.55M

16.86%

U.S. Other P&R

71.41M

13.01%

Relevant data have not been disclosed by the company yet.

By Business

By Region

By BusinessUSD

Name

Revenue

Proportion

International Reconstructive

128.99M

23.50%

U.S. Reconstructive

128.98M

23.50%

U.S. Bracing & Support

126.98M

23.13%

International P&R

92.55M

16.86%

U.S. Other P&R

71.41M

13.01%

Shareholding Stats

Updated: Fri, Jan 16

Shareholders

Shareholder Types

Shareholders

Proportion

BlackRock Institutional Trust Company, N.A.

13.92%

The Vanguard Group, Inc.

11.19%

American Century Investment Management, Inc.

8.27%

Dimensional Fund Advisors, L.P.

4.86%

Rubric Capital Management LP

4.81%

Other

56.95%

Shareholders

Proportion

BlackRock Institutional Trust Company, N.A.

13.92%

The Vanguard Group, Inc.

11.19%

American Century Investment Management, Inc.

8.27%

Dimensional Fund Advisors, L.P.

4.86%

Rubric Capital Management LP

4.81%

Other

56.95%

Shareholder Types

Shareholders

Proportion

Investment Advisor

62.74%

Investment Advisor/Hedge Fund

29.50%

Hedge Fund

16.32%

Research Firm

4.93%

Individual Investor

1.67%

Bank and Trust

1.23%

Pension Fund

1.01%

Sovereign Wealth Fund

0.05%

Family Office

0.04%

Institutional Shareholding



Updated: Mon, Dec 8

Reporting Period

No. of institutions

Shares Held

Proportion

Change

2025Q4

617

68.12M

125.63%

--

2025Q3

641

68.12M

128.26%

-1.19M

2025Q2

651

69.44M

130.24%

+2.07M

2025Q1

629

67.38M

125.09%

-4.06M

2024Q4

625

63.48M

125.04%

+1.28M

2024Q3

599

62.09M

124.13%

-57.94K

2024Q2

602

61.71M

121.92%

+2.05M

2024Q1

635

59.58M

125.47%

-9.23M

2023Q4

647

58.62M

120.02%

+2.97M

2023Q3

636

55.66M

121.59%

+429.23K

Shareholder Activity



Name

Shares Held

Proportion

Change

Chg %

Date

BlackRock Institutional Trust Company, N.A.

7.96M

13.92%

-55.88K

-0.70%

Sep 30, 2025

The Vanguard Group, Inc.

6.49M

11.35%

+120.78K

+1.90%

Sep 30, 2025

American Century Investment Management, Inc.

4.73M

8.27%

-6.26K

-0.13%

Sep 30, 2025

Dimensional Fund Advisors, L.P.

2.97M

5.2%

+51.20K

+1.75%

Sep 30, 2025

Rubric Capital Management LP

2.75M

4.81%

+2.75M

--

Sep 30, 2025

Davenport Asset Management

2.81M

4.91%

+50.85K

+1.85%

Sep 30, 2025

Dorsey Asset Management LLC

2.40M

4.2%

-153.86K

-6.03%

Sep 30, 2025

State Street Investment Management (US)

2.35M

4.11%

-138.65K

-5.57%

Sep 30, 2025

Hood River Capital Management LLC

1.73M

3.02%

-7.30K

-0.42%

Sep 30, 2025

River Road Asset Management, LLC

1.44M

2.52%

+1.06K

+0.07%

Sep 30, 2025

Related ETFs



Updated: Sat, Dec 6

Name

Proportion

State Street SPDR S&P Health Care Equipment ETF

1.83%

Invesco S&P SmallCap Health Care ETF

1.09%

Invesco S&P SmallCap 600 Pure Value ETF

0.45%

State Street SPDR S&P 600 Small Cap Value ETF

0.25%

iShares S&P Small-Cap 600 Value ETF

0.24%

iShares U.S. Medical Devices ETF

0.21%

Humankind US Stock ETF

0.2%

State Street SPDR S&P SmallCap 600 ESG ETF

0.18%

Avantis US Small Cap Equity ETF

0.18%

Invesco S&P SmallCap 600 Revenue ETF

0.16%

State Street SPDR S&P Health Care Equipment ETF

Proportion1.83%

Invesco S&P SmallCap Health Care ETF

Proportion1.09%

Invesco S&P SmallCap 600 Pure Value ETF

Proportion0.45%

State Street SPDR S&P 600 Small Cap Value ETF

Proportion0.25%

iShares S&P Small-Cap 600 Value ETF

Proportion0.24%

iShares U.S. Medical Devices ETF

Proportion0.21%

Humankind US Stock ETF

Proportion0.2%

State Street SPDR S&P SmallCap 600 ESG ETF

Proportion0.18%

Avantis US Small Cap Equity ETF

Proportion0.18%

Invesco S&P SmallCap 600 Revenue ETF

Proportion0.16%

Dividend



A total of 0.00 USD has been distributed in dividends over the past 5 years.

Date

Dividend

Record Date

Payment Date

Ex-dividend Date

No Data

Stock Splits



Date

Ex-dividend Date

Type

Ratio

Mar 18, 2022

Merger

3→1

Mar 18, 2022

Merger

3→1

Mar 18, 2022

Merger

3→1

Mar 18, 2022

Merger

3→1

Date

Ex-dividend Date

Type

Ratio

Mar 18, 2022

Merger

3→1

Mar 18, 2022

Merger

3→1

Mar 18, 2022

Merger

3→1

Mar 18, 2022

Merger

3→1